Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Gert M. Kostner"'
Autor:
Karam M. Kostner, Gert M. Kostner
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 1, Pp 1-14 (2017)
Initially, lipoprotein (a) [Lp(a)] was believed to be a genetic variant of lipoprotein (Lp)-B. Because its lipid moiety is almost identical to LDL, Lp(a) has been deliberately considered to be highly atherogenic. Lp(a) was detected in 1963 by Kare Be
Externí odkaz:
https://doaj.org/article/d9d8547c023b4e059f1bb102963bcd7e
Autor:
Elke M. Wagner, Dagmar Kratky, Guenter Haemmerle, Andelko Hrzenjak, Gert M. Kostner, Ernst Steyrer, Rudolf Zechner
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 2, Pp 356-365 (2004)
Lipoprotein lipase (LPL) is the only known enzyme in the capillary endothelium of peripheral tissues that hydrolizes plasma triglycerides and provides fatty acids (FAs) for their subsequent tissue uptake. Previously, we demonstrated that mice that ex
Externí odkaz:
https://doaj.org/article/a54297c35c8c42339798866c061998c8
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 12, Pp 2255-2263 (1999)
LP[a] is one of the most atherogenic lipoproteins consisting of an LDL-like core particle and a covalently linked glycoprotein of variable size. Due to its structural features, its heterogeneity and instability, there are great difficulties in standa
Externí odkaz:
https://doaj.org/article/7ba6beb75438478fa678c65ad680e039
Publikováno v:
Atherosclerosis. 274
Lipoprotein (a) (Lp(a)) is a cholesterol-rich lipoprotein known since 1963. In spite of extensive research on Lp(a), there are still numerous gaps in our knowledge relating to its function, biosynthesis and catabolism. One reason for this might be th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39944502f3a6fa820929743d0a24318a
https://pubmed.ncbi.nlm.nih.gov/29747086
https://pubmed.ncbi.nlm.nih.gov/29747086
Publikováno v:
LaboratoriumsMedizin. 39:71-80
Zusammenfassung: Lipoprotein(a) [Lp(a)] ist eines der atherogensten Lipoproteine. Es besteht aus einem low density lipoprotein (LDL)-Partikel und dem spezifischen Glykoprotein Apo(a). Apo(a) ist homolog zu Plasminogen, weist jedoch im Gegensatz dazu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee669ebe34301de35d22366d74e0f550
https://doi.org/10.1515/labmed-2015-0002
https://doi.org/10.1515/labmed-2015-0002
Autor:
Christoph Wanner, Gert M. Kostner, Bernhard Paulweber, Martin Merkel, Ulrich Laufs, F. U. Beil, Dirk Müller-Wieland, W. Riesen, Ioanna Gouni-Berthold, A. von Eckardstein, Georg Noll, Elisabeth Steinhagen-Thiessen, Wolfgang Koenig, Armin Steinmetz, Bernhard Föger, Hermann Toplak, J.R. Schaefer, Gerald Klose, Ulf Landmesser, Eberhard Windler, Winfried März, Frank Leistikow, Hans Dieplinger, Klaus G. Parhofer
Publikováno v:
Der Internist. 55:601-606
ZusammenfassungKürzlich wurde im Namen der American Heart Association und des American College of Cardiology eine Leitlinie zur Cholesterinsenkung und Reduktion des Risikos für arteriosklerotische Herz-Kreislauf-Erkrankungen veröffentlicht. Sie ni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6987eec09750b57d276a31a17338ab1f
https://doi.org/10.1007/s00108-014-3492-z
https://doi.org/10.1007/s00108-014-3492-z
Publikováno v:
LaboratoriumsMedizin. 39
Lipoprotein(a) [Lp(a)] is one of the most atherogenic lipoproteins consisting of a core low-density lipoprotein particle and the specific glycoprotein apo(a). Apo(a) is homologous to plasminogen yet in contrast exhibits a specific size polymorphism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb4416ed5a4816d18c7a424988a5aabd
https://doi.org/10.1515/labmed-2015-0095
https://doi.org/10.1515/labmed-2015-0095
Variation of Lp(a) Plasma Concentrations in Health and Disease~!2009-11-03~!2010-02-06~!2010-09-08~!
Publikováno v:
The Open Clinical Chemistry Journal. 3:72-89
Lipoprotein(a) (Lp(a)) is an established risk marker of cardiovascular diseases which is independent from other risk markers. The main difference of Lp(a) compared to low density lipoprotein (LDL) is the apo(a) residue which is covalently bound to ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db2d8881b5b50a7b1d40c0fb0f992d5d
https://doi.org/10.2174/1874241601003010072
https://doi.org/10.2174/1874241601003010072
Autor:
Bernd Genser, Rüdiger Siekmeier, Hubert Scharnagl, Winfried März, Gert M. Kostner, Tanja B. Grammer, Tatjana Stojakovic
Publikováno v:
Kardiologie up2date. 5:302-308
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31f4268aee17210ab6b96aeaa26d71a5
https://doi.org/10.1055/s-0029-1243849
https://doi.org/10.1055/s-0029-1243849
Publikováno v:
The Open Clinical Chemistry Journal. 1:79-91
Decades after its first description by Berg 1963 lipoprotein(a) (Lp(a)) is an established risk marker of cardio- vascular diseases which is independent from other risk markers. The main difference of Lp(a) compared to LDL is the apo(a) residue which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40224929f45d83cade52d61ec8ff8c2b
https://doi.org/10.2174/1874241600801010079
https://doi.org/10.2174/1874241600801010079